Aonong Biological's pig sales in February were 148,000 head, with a stock of 778,900 head

Radar Finance | Feng Xiuyu Edited | Li Yihui

On March 5th, Aonong Bio (Stock Code: 603363) released a report on its main operational data for the pig farming business as of February 2026. The announcement shows that the company’s pig sales in February 2026 reached 148,000 heads, a 52.10% increase year-over-year, but an 11.12% decrease compared to the previous month. The pig inventory was 778,900 heads, up 51.74% year-over-year and up 2.67% month-over-month, with a 4.78% increase since the end of December 2025.

The company stated that it is actively promoting the optimization of pig farming capacity, adjusting breeding layout, scale, and breed structure, and adhering to the strategy of “stability first, continuous cost reduction,” focusing resources on developing advantageous production capacity. The announcement has not been audited and is for investors to understand the company’s farming business overview. It does not constitute any promise or guarantee, and investors should be aware of investment risks.

According to Tianyancha data, Aonong Bio was established on April 26, 2011, with a registered capital of 2,605,582,626 RMB. The legal representative is Wu Youlin. The registered address is at the intersection of Xingting Road and Baolian Road in Jinfeng Economic Development Zone, Xiangcheng District, Zhangzhou City, Fujian Province. Its main businesses include feed, pig farming, and food industries.

Currently, the company’s chairman is Su Mingcheng, the secretary is Peng Jiang, and it has 5,220 employees.

The company has equity participation in 333 subsidiaries, including Sichuan Aokai Biotechnology Co., Ltd., Suqian Aonong Agriculture and Animal Husbandry Co., Ltd., Yongxin Aochuang Ecological Agriculture Technology Co., Ltd., Leshan Aomu Livestock Co., Ltd., and Yongxin Aoshun Ecological Agriculture Technology Co., Ltd.

In terms of performance, the company’s revenue for 2022, 2023, and 2024 was 21.613 billion RMB, 19.458 billion RMB, and 8.763 billion RMB, respectively, with year-over-year growth rates of 19.82%, -9.97%, and -54.97%. Net profit attributable to the parent was -1.039 billion RMB, -3.651 billion RMB, and 579 million RMB, with year-over-year growth rates of 31.64%, -251.59%, and 115.87%. During the same period, the company’s asset-liability ratio was 81.61%, 103.69%, and 67.80%.

Regarding risks, Tianyancha data shows the company has 1,836 internal Tianyan risks, 3,145 surrounding risks, 622 historical risks, and 1,229 warning risks.